Found: 24
Select item for more details and to access through your institution.
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.
- Published in:
- European Radiology, 2023, v. 33, n. 2, p. 1174, doi. 10.1007/s00330-022-09053-2
- By:
- Publication type:
- Article
CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41011-4
- By:
- Publication type:
- Article
Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 305, doi. 10.1016/j.clcc.2021.05.007
- By:
- Publication type:
- Article
Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10972-6
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 836, doi. 10.1038/s41416-022-01854-y
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials.
- Published in:
- Oncology, 2012, v. 83, n. 5, p. 241, doi. 10.1159/000339534
- By:
- Publication type:
- Article
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 7, p. 993, doi. 10.3109/0284186X.2015.1034877
- By:
- Publication type:
- Article
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 5, p. 956, doi. 10.3109/0284186X.2012.752580
- By:
- Publication type:
- Article
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 349, doi. 10.1186/1471-2407-12-349
- By:
- Publication type:
- Article
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.751453
- By:
- Publication type:
- Article
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1026, doi. 10.3390/cancers14041026
- By:
- Publication type:
- Article
Incidence of Cancer in Patients with Irritable Bowl Syndrome.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5911, doi. 10.3390/jcm10245911
- By:
- Publication type:
- Article
Nerve Fibers in the Tumor Microenvironment Are Co-Localized with Lymphoid Aggregates in Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 490, doi. 10.3390/jcm10030490
- By:
- Publication type:
- Article
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 5, p. 863, doi. 10.1002/ijc.34760
- By:
- Publication type:
- Article
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase III trial FIRE‐3 (AIO KRK‐0306)
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 1, p. 112, doi. 10.1002/ijc.33775
- By:
- Publication type:
- Article
Radiotherapeutic treatment options for oligotopic malignant liver lesions.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 6, p. 1538, doi. 10.1002/ijc.32230
- By:
- Publication type:
- Article
Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 8, p. 1918, doi. 10.1002/ijc.30592
- By:
- Publication type:
- Article
Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan-based randomized first-line trial.
- Published in:
- Cancer Science, 2013, v. 104, n. 6, p. 718, doi. 10.1111/cas.12148
- By:
- Publication type:
- Article